Sign in

CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
271467257
Phone
(858) 333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Executive or director change
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 4 Conversion 10% owner acquired 542,628 shares (conversion)
  10. SC 13G Stake Amended Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Bylaws or fiscal year change
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 424B4 Offering Prospectus
  15. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  16. EFFECT Other Notice of Effectiveness
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 9 of 11 · 202 filings